Financhill
Back

Mereo BioPharma Group PLC Vs. Neurogene Industry Stock Comparison

Sell
37

MREO
Mereo BioPharma Group PLC

Last Price:
$3.38
Seasonality Move:
18.25%
Sell
12

NGNE
Neurogene

Last Price:
$22.57
Seasonality Move:
18.83%
Sell
37
Mereo BioPharma Group PLC (MREO) is a Sell

Is Mereo BioPharma Group PLC a Buy, Sell or Hold?

  • The current Mereo BioPharma Group PLC [MREO] share price is $3.34. The Score for MREO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • MREO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
12
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $22.64. The Score for NGNE is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MREO Stock Price Chart

What is Mereo BioPharma Group PLC's stock price today?

  • The Mereo BioPharma Group PLC share price today is $3.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MREO is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $22.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing slight selling pressure.

MREO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 37.39 Sell
Chaikin Money Flow: 1132926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.39 - 3.73) Sell
Bollinger Bands (100): (3.69 - 4.47) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.64 Sell
Relative Strength Index (14 RSI): 40.23 Sell
Chaikin Money Flow: -23511 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.09 - 26.45) Sell
Bollinger Bands (100): (26.19 - 50.01) Sell

MREO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.52 Sell
20-day SMA: 3.57 Sell
50-day SMA: 3.91 Sell
200-day SMA: 3.73 Sell
8-day EMA: 3.46 Sell
20-day EMA: 3.59 Sell
50-day EMA: 3.79 Sell
200-day EMA: 3.65 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.05 Sell
20-day SMA: 23.34 Sell
50-day SMA: 37.38 Sell
200-day SMA: 37.89 Sell
8-day EMA: 22.93 Sell
20-day EMA: 25.32 Sell
50-day EMA: 32.11 Sell
200-day EMA: 35.01 Sell

Mereo BioPharma Group PLC Earnings Growth & MREO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.

Mereo BioPharma Group PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):